84. Sarcoidosis Clinical trials / Disease details
Clinical trials : 149 / Drugs : 202 - (DrugBank : 78) / Drug target genes : 66 - Drug target pathways : 169
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02625558 (ClinicalTrials.gov) | April 2015 | 26/5/2015 | Riociguat for Sarcoidosis Associated Pulmonary Hypertension | A Double Blind, Placebo Controlled Trial of Oral Riociguat for Sarcoidosis Associated Pulmonary Hypertension | Sarcoidosis | Drug: Riociguat;Drug: Placebo | University of Cincinnati | NULL | Recruiting | 18 Years | N/A | Both | 60 | Phase 4 | United States |